Senators Launch Investigations on Orphan Drugs

Drug Industry Daily
A A
Two groups of senators have launched investigations into orphan drugs to examine whether drugmakers are misusing the designation and overcharging for treatments.

To View This Article:

Login

Subscribe To Drug Industry Daily